期刊文献+

Exendin-4对人肝癌细胞HepG2增殖的影响

Effect of Exendin-4 on proliferation of human hepatocellular carcinoma cells HepG2
下载PDF
导出
摘要 目的:探讨Exendin-4对人肝癌细胞HepG2增殖的影响。方法:给予不同浓度(0.1、1.0、10.0、100.0nmol/L)的Exendin-4刺激HepG2,使用cell counting kit-8(CCK-8)试剂检测细胞增殖,流式细胞术检测细胞周期分布。结果:Exendin-4在0.1、1.0nmol/L水平对人肝癌细胞HepG2无明显促进增殖作用,在10.0、100.0nmol/L水平有明显促进增殖作用,差异具有统计学意义(P<0.05),呈现出浓度、时间依赖性地促进HepG2的增殖,并且随着Exendin-4水平的增加,HepG2G0/G1期细胞比例逐渐下降(P<0.05),S期及G2/M期细胞比例逐渐上升(P<0.05)。结论:Exendin-4在低浓度时对人肝癌细胞HepG2无明显促进增殖作用,但浓度增加到一定水平时具有促进增殖作用,且呈现时间依赖性促进H epG2的增殖效应。 Objective: To investigate the effect of Exendin-4 on growth and proliferation of human hepatocellular carcinoma cells HepG2.Methods: HepG2 cells were cultured in vitro with Exendin-4 at different concentrations(0.1,1.0,10.0,100.0 nmol/L).Cell proliferation was detected by cell counting kit-8 reagents,and cell cycles were measured by flow cytometry.Results: No significant difference in cell proliferation was detected between control and Exendin-4 groups at the concentrations of 0.1 and 1.0 nmol/L,while difference in cell proliferation was significant between control and Exendin-4 groups at the concentrations of 10.0 and 100.0 nmol/L(P〈0.05).Exendin-4 promoted the proliferation of HepG2 in a dose and time-dependent manner.The cell ratio in G0-G1 phase decreased gradually(P〈0.05) and the ratio in S/G2-M phase was increased(P〈0.05).Conclusions:It is not obvious in promoting Proliferation of human hepatocellular carcinoma cells when Exendin-4 is at a low concentration.However,it has the effect of promoting Proliferation when the concentration increase to a certain level.Exendin-4 promoted the proliferation of HepG2 in a time-dependent manner.
出处 《海南医学院学报》 CAS 2012年第8期1034-1036,共3页 Journal of Hainan Medical University
基金 中国高校医学期刊临床专项资金项目(112210254)~~
关键词 EXENDIN-4 人肝癌细胞 增殖 Exendin-4; Human hepatocellular carcinoma cells; Proliferation
  • 相关文献

参考文献9

  • 1Vaidya HB,Goyal RK.Glucagon-like peptides-1modu-lators as newer target for diabetes[J].Curr Drug Tar-gerts,2008,9(10):911-920.
  • 2Gautier JF,Choukem SP,Girard J.Physiology of incre-tins(GIP and GLP-1)and abnormalities in type 2diabe-tes[J].Diabetes Metab,2008,34(Suppl 2):65-72.
  • 3Hemminki K,Li XJ,Sundquist J,et al.Risk of cancerfollowing hospitalization for type 2diabetes[J].Oncolo-gist,2010,15(6):548-555.
  • 4Gupta NA,Mells J,Dunham RM,et al.Glucagon-likepeptide-1receptor is present on human hepatocytes andhas a direct role in decreasing hepatic steatosis in vitroby modulating elements of the insulin signaling pathway[J].Hepatology,2010,51:1584-1592.
  • 5Farilla L,Hui H,Bertolotto C,et al.Glucagon-like pep-tide-1promotes islet cell growth and inhibits apoptosisin Zucker diabetic rats[J].Endocrinology,2002,143(11):4397-4408.
  • 6Li Y,Tweedie D,Mattson MP,et al.Enhancing theGLP-1receptor signaling pathway leads to proliferationand neuroprotection in human neuroblastoma cells[J].JNeurochem,2010,113(6):1621-1631.
  • 7Aviv V,Meivar-Levy I,Rachrmut IH,et al.Exendin-4promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdifferentiation process[J].J Biol Chem,2009,284(48):33509-33520.
  • 8Knudsen LB,Madsen LW,Andersen S,et al.Glucagon-like peptide-1receptor agonists activate rodent thyroidC-cells causing calcitonin release and C-cell proliferation[J].Endocrinology,2010,151(4):1473-1486.
  • 9陈云辉,王甲汉,李志清,易朝辉.Exendin-4对严重烫伤大鼠早期心肌细胞凋亡的影响[J].南方医科大学学报,2011,31(6):1101-1104. 被引量:3

二级参考文献12

  • 1Enari M, Sakahira H, Yokoyama H, et al. A caspase-activated dnase that degrades DNA during apoptosis, and its inhibitor ICAD [J]. Nature, 1998, 391(6662): 43-50.
  • 2Bullock BP, Heller RS, Habener JF. Tissue distribution of messen- ger ribonucleic acid encoding the rat glucagon-like peptide-1 recep- tor[J]. Endocrinology, 1996, 137(7): 2968-78.
  • 3Wei Y, Mojsov S. Distribution of GLP-1 and pacap receptors in human tissues[J]. Acta Physiol Stand, 1996, 157(3): 355-7.
  • 4Parikh P, Bhashyam S, Zhao T, et al. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts [J]. J Pharmacol Exp Ther,2006, 317(3): 1106-13.
  • 5Kavianipour M, Ehlers MR, Malmberg K, et al. Glucagon-like peptide-1(7-36)amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium [J]. Peptides, 2003, 24(4): 569-78.
  • 6Green, BD, Flatt PR, Bailey CJ. Dipeptidyl peptidase Ⅳ(DPP Ⅳ) inhibitors:a newly emerging drug class for the treatment of type 2 diabetes[J]. Diab Vasc Dis Res, 2006, 3(3): 159-65.
  • 7Mager DE, Abernethy DR, Egan JM, et al. Exendin-4 pharmaco dynamics: insights from the hyperglycemic clamp technique [J]. J Pharmacol Exp Ther, 2004, 311 (2): 830-5.
  • 8Hansotia T, Maida A, Flock G, et al. Extrapancreatic incretin receptors modulate glucose homeostasis,body weight,and energy expenditure[J]. J Clin Invest, 2007, 117(1): 143-52.
  • 9Degn K_B, Brock B, Juhl CB, et al. Effect of intravenous infusion of exenatide(synthetic exendin-4)on glucose-dependent insulin secretion and counterregulation during hypoglycemia [J]. Diabetes, 2004, 53(9): 2397-403.
  • 10陈发明.烧烫伤动物模型的研制[M].重庆:重庆大学出版社,1997.39-40.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部